nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 29th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 12:08PM
|
Aug 29th, 2022 12:08PM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 28th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 05:07AM
|
Aug 28th, 2022 05:07AM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 27th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 04:27AM
|
Aug 27th, 2022 04:27AM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 25th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 09:06AM
|
Aug 25th, 2022 09:06AM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 23rd, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 10:59AM
|
Aug 23rd, 2022 10:59AM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 21st, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 12:43PM
|
Aug 21st, 2022 12:43PM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 20th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 02:20PM
|
Aug 20th, 2022 02:20PM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 19th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 12:43PM
|
Aug 19th, 2022 12:43PM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 18th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 04:27AM
|
Aug 18th, 2022 04:27AM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:irwd
|
https://www.indeed.com/cmp/ironwood-pharmaceuticals
|
Aug 17th, 2022 12:00AM
|
Open
|
Ironwood Pharmaceuticals
|
|
Healthcare
|
Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031.The company is publicly listed on NASDAQ with the symbol "IRWD".
|
RRv1_100M_500M
|
Cambridge, Massachusetts
|
|
|
|
4.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32.00
|
32.00
|
4.00
|
4.30
|
2.90
|
3.50
|
4.20
|
13.00
|
More than one month
|
15.00
|
DIFFICULT
|
14.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 10:06AM
|
Aug 17th, 2022 10:06AM
|
Ironwood Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|